CLINICAL_TRIALS
trial_result
· 2016-03-30
Clinical Trial Update: Coenzyme Q10 in Huntington's Disease (HD) [Phase 3]
Summary
A Phase 3 trial of Coenzyme Q10 for Huntington's disease was terminated, and the results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Huntington's Disease | Phase 3 | Status: TERMINATED | Results posted: 2016-03-30